Ranbaxy: Press Statement

PRINCETON, NJ, February 15, 2007  - Ranbaxy Inc., said today that federal officials conducted a search at its New Jersey offices on Feb 14, 2007.

Ranbaxy said that this action has come as a surprise. The company is not aware of any wrongdoing. It is co-operating fully with the officials.

Meanwhile, the company’s operations continue as normal.

Ranbaxy, today, operates in a complex global business environment in one of the most highly competitive and regulated industries. Over the decades, the company has consistently delivered high quality affordable medicines to millions across the world-including those in the most demanding markets.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies", resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 9 countries

USA Contacts :

Chuck Caprariello
Vice President of Corporate Communications and Government Affairs
(609) 462-7354 (cell)
(609) 688-0180
(609) 720-5615

Robert Ferris
RF|Binder Partners Inc.
(212) 995-7505
(201) 888-5234 (cell) 

India Contacts :

Ramesh L. Adige
Executive Director- Corporate Affairs and Global Corporate Communications
Ranbaxy Laboratories Ltd.
Plot 90, Sector 32, Gurgaon
Haryana122001, India
Tel: +91-124-4135000
e-mail: ramesh.adige@ranbaxy.com

or

Raghu Kochar
Director-Corporate Communications
Ranbaxy Laboratories Ltd.
Plot 90, Sector 32, Gurgaon
Haryana122001, India
Tel: +91-124-4135141
Mobile: 9811617256
e-mail: raghu.kochar@ranbaxy.com

or

Krishnan Ramalingam
Sr.Manager- Corporate Communications
Plot 90, Sector 32, Gurgaon
Haryana122001, India
Tel: +91-124-4135143
Mobile: 9810042540
e-mail: krishnan.ramalingam@ranbaxy.com  

Posted: February 2007


View comments

Hide
(web4)